Pharmacogenomics Reporter GenomeWeb News Premium Content Existing subscribers login here. New to Pharmacogenomics Reporter? For a trial subscription click here.

Dx Shops’ Flexibility Will Encourage
Co-Development Alliances, Qiagen CEO

[December 12, 2007]

By Turna Ray

In today’s risk-averse regulatory and reimbursement environment, “the pharmaceutical industry cannot take more risk into their projects at very early phases,” Qiagen CEO Peer Schatz said at a personalized medicine conference last month hosted by HPCGG.

Login | Subscribe